My Shoulder Had Been Bothering Me for Months — Here's What Changed
I'm not someone who reaches for a solution the moment something feels off. I tend to sit with discomfort for a while, convince myself it'll sort itself out, and then eventually accept that it isn't going to. That's exactly what happened with my shoulder. A persistent ache — not dramatic, not debilitating, just always there — that I'd been carrying around for the better part of six months. If you train regularly or spend long hours at a desk, you'll know the kind of thing I mean. It nags. It limits. You start working around it without even noticing.
Why I Started Researching This
As someone who founded Irish Peptides & Nutrition, I was already deep into the research on peptides before I ever considered using them personally. BPC-157 kept coming up in the literature — specifically in the context of soft-tissue and joint recovery. What made me take it seriously wasn't a forum post or a fitness influencer. It was the consistency of the mechanistic research. There was enough there to make me want to understand it better.
In Ireland, the peptide space is still relatively early-stage in terms of public awareness. Most people here are only beginning to encounter this kind of research, which is part of why I started this site — to give Irish people access to clear, honest information rather than the noise that tends to dominate online spaces. BPC-157 is a peptide I felt I could speak to eventually, but I wanted to do it properly. That meant researching it thoroughly first, and then — when I felt informed enough — running a personal protocol and observing the results honestly.
What the Research Actually Says
BPC-157 stands for Body Protection Compound-157. It's a synthetic peptide derived from a protein found naturally in gastric juice. The research — primarily conducted in animal models — suggests it may support tissue healing through several mechanisms. Studies indicate it appears to promote angiogenesis, which is the formation of new blood vessels, and may support the upregulation of growth hormone receptors in tendon fibroblasts. There's also research suggesting involvement in nitric oxide pathways, which play a role in inflammation and blood flow regulation.
What's important to say clearly: human clinical trials on BPC-157 are limited. Much of what we know comes from preclinical research. I'm not going to overstate the evidence. What I can say is that the mechanistic plausibility is there — there are reasonable biological pathways by which this peptide could support soft-tissue recovery — and the research, while not conclusive for humans, is genuinely interesting. This is a compound worth watching as the science develops. It is not a treatment, not a cure, and anyone telling you otherwise is overstating the evidence.
For research purposes, BPC-157 is typically studied in the context of tendon, ligament, and joint tissue. The gastric peptide origin may also have relevance for gut-lining integrity, though that was not my personal focus.
My Personal Experience
I ran BPC-157 at 0.5mg daily as a standalone protocol, starting it after I had completed a Glow Pen cycle. The Glow Pen itself is a stack combining GHK-Cu, BPC-157, and TB-500 — but I wanted to run BPC-157 solo afterward to get a cleaner sense of what it was contributing individually. That kind of isolation matters to me when I'm trying to observe results honestly rather than attribute everything to a combination.
The shoulder. That's the specific thing I was paying attention to. By a few weeks in, the chronic inflammation that had been sitting there for months was noticeably reduced. I want to be careful about how I say this, because individual response varies and I'm aware of that — but my personal experience was clear enough that I felt it warranted writing about. The ache that I'd been working around in training wasn't there in the same way. I wasn't favouring that side. I could move through a full range of motion without that familiar dull resistance.
I didn't change my training volume significantly during that period. I didn't start doing anything radically different with my sleep or nutrition. The main variable was the protocol. I can't tell you with certainty that BPC-157 was the cause — that's not how personal experience works, and I won't pretend otherwise. What I can tell you is that the timing was notable, and that the change was measurable in a way that felt distinct from normal fluctuation.
That's the honest version. No dramatising, no certainty I don't have.
What I'd Tell Someone Considering This
If you're in Ireland and you're researching BPC-157 for the first time, here's what I'd actually say to you — not as a company, but as someone who has run this personally.
Start with bloodwork. Know your baseline inflammation markers, your hormonal picture, your general health status. Peptides are research compounds, and going into any protocol blind is not something I'd recommend. You want data before and after so you can actually evaluate what you're observing.
Start low. The 0.5mg daily protocol is what I ran, and I wouldn't suggest jumping higher without good reason. More is not always more, particularly when you're in the early stages of understanding how your body responds.
Track everything. Keep a simple log. Subjective notes — how does the target area feel, how is your sleep, energy, training quality. You're running an n=1 experiment, and if you don't record your observations systematically, they become very difficult to interpret later.
Be honest with yourself about what you're noticing. It's easy to want something to work and then convince yourself it is. It's equally easy to be too dismissive when results are subtle. Neither extreme is useful. Try to observe without agenda.
And finally — this is not medical advice. I'm a founder who researches peptides and runs personal protocols. I'm not your doctor, and you should be talking to one before starting anything, particularly if you have any underlying conditions or are on medication.
Summary
BPC-157 is one of the more researched peptides in the soft-tissue and joint recovery space, with a reasonable mechanistic basis that makes the preclinical findings worth paying attention to. My personal protocol — 0.5mg daily, run standalone after a Glow Pen cycle — produced results I could feel in a shoulder that had been bothering me for months. I'm honest about the fact that individual variation is real and that my experience isn't a guarantee of yours. But I thought it was worth documenting clearly, in plain language, for an Irish audience that deserves straightforward information rather than hype.
If you want to dig further into the research, explore protocol options, or use some of the free tools I've built for this — including dosing calculators and cycle planners — head over to irishpeptides.ie/free-tools. Everything there is free to use and built to help you make more informed decisions.